Gene: TMPRSS6
Official Full Name: transmembrane serine protease 6provided by HGNC
Gene Summary: The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20305 | TMPRSS6 Knockout cell line (HEK293) | Human | TMPRSS6 | 1:3~1:6 | Negative | Online Inquiry |
TMPRSS6 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the function and regulation of the TMPRSS6 gene, which encodes a serine protease involved in iron metabolism. These cell lines have been created through advanced CRISPR-Cas9 technology, resulting in precise gene editing that knocks out the TMPRSS6 coding region. This leads to a complete loss of the protease's enzymatic activity, allowing researchers to investigate the downstream effects of its absence on cellular iron homeostasis and potential implications in disorders such as iron-refractory iron deficiency anemia (IRIDA).
The fundamental mechanism of action involves the regulatory role of TMPRSS6 in modulating hepcidin expression, a key hormone that controls systemic iron levels. By utilizing these knockout cell lines, scientists can elucidate the pathways through which TMPRSS6 influences iron absorption and distribution, providing valuable insights into the pathophysiology of iron-related diseases.
Scientific importance is underscored by the growing need for more thorough understanding of iron regulation, as it is crucial not only for hematopoiesis but also for various metabolic processes. These cell lines are invaluable in research settings, allowing for high-throughput screening of potential therapeutic compounds and the development of gene therapy strategies.
Compared to traditional wild-type cell lines, TMPRSS6 Gene Knockout Cell Lines offer distinct advantages, including enhanced specificity for iron metabolism studies and the ability to model diseases with a defined genetic factor. They allow researchers to obtain clearer data regarding the effects of TMPRSS6 loss without confounding factors that may arise from the presence of functional alleles.
For researchers, clinicians, and pharmaceutical companies focused on hematology and metabolic disorders, these cell lines epitomize a significant advancement in the quest to better understand and combat iron-related diseases. By using TMPRSS6 Gene Knockout Cell Lines, investigators can facilitate groundbreaking discoveries that could lead to novel therapeutic approaches. Our company, a leader in cutting-edge biotechnological solutions, boasts extensive expertise in genetic engineering and a commitment to providing high-quality research tools that empower scientific innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.